Home › Uveal Melanoma › Wisconsin
Uveal Melanoma clinical trials in Wisconsin
3 studies for Uveal Melanoma are looking for participants at sites in Wisconsin.
Cities in Wisconsin
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- University of Wisconsin Health, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07804186Neoadjuvant Darovasertib in Primary Uveal Melanoma
- University of Wisconsin Health, Madison
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University Of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecruitingPhase 2/3
All ages · All sexes · Updated Apr 2, 2026 · NCT06581406From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.